Literature DB >> 16061482

The utrophin A 5'-untranslated region confers internal ribosome entry site-mediated translational control during regeneration of skeletal muscle fibers.

Pedro Miura1, Jennifer Thompson, Joe V Chakkalakal, Martin Holcik, Bernard J Jasmin.   

Abstract

Utrophin up-regulation in muscle fibers of Duchenne muscular dystrophy patients represents a potential therapeutic strategy. It is thus important to delineate the regulatory events presiding over utrophin in muscle in attempts to develop pharmacological interventions aimed at increasing utrophin expression. A number of studies have now shown that under several experimental conditions, the abundance of utrophin is increased without a corresponding elevation in its mRNA. Here, we examine whether utrophin expression is regulated at the translational level in regenerating muscle fibers. Treatment of mouse tibialis anterior muscles with cardiotoxin to induce muscle degeneration/regeneration led to a large (approximately 14-fold) increase in the levels of utrophin A with a modest change in expression of its transcript (40%). Isolation of the mouse utrophin A 5'-untranslated region (UTR) revealed that it is relatively long with a predicted high degree of secondary structure. In control muscles, the 5'-UTR of utrophin A caused an inhibition upon translation of a reporter protein. Strikingly, this inhibition was removed during regeneration, indicating that expression of utrophin A in regenerating muscles is translationally regulated via its 5'-UTR. Using bicistronic reporter vectors, we observed that this translational effect involves an internal ribosome entry site in the utrophin A 5'-UTR. Thus, internal ribosome entry site-mediated translation of utrophin A can, at least partially, account for the discordant expression of utrophin A protein and transcript in regenerating muscle. These findings provide a novel target for up-regulating levels of utrophin A in Duchenne muscular dystrophy muscle fibers via pharmacological interventions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061482     DOI: 10.1074/jbc.M503994200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Spurious splicing within the XIAP 5' UTR occurs in the Rluc/Fluc but not the betagal/CAT bicistronic reporter system.

Authors:  Martin Holcik; Tyson Graber; Stephen M Lewis; Charles A Lefebvre; Eric Lacasse; Stephen Baird
Journal:  RNA       Date:  2005-09-21       Impact factor: 4.942

Review 2.  Searching for IRES.

Authors:  Stephen D Baird; Marcel Turcotte; Robert G Korneluk; Martin Holcik
Journal:  RNA       Date:  2006-09-06       Impact factor: 4.942

3.  Conserved regions of the DMD 3' UTR regulate translation and mRNA abundance in cultured myotubes.

Authors:  C Aaron Larsen; Michael T Howard
Journal:  Neuromuscul Disord       Date:  2014-05-22       Impact factor: 4.296

Review 4.  Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances.

Authors:  Guy L Odom; Paul Gregorevic; Jeffrey S Chamberlain
Journal:  Biochim Biophys Acta       Date:  2006-09-26

5.  Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice.

Authors:  Guy L Odom; Paul Gregorevic; James M Allen; Eric Finn; Jeffrey S Chamberlain
Journal:  Mol Ther       Date:  2008-07-29       Impact factor: 11.454

6.  Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles.

Authors:  Christine Péladeau; Aatika Ahmed; Adel Amirouche; Tara E Crawford Parks; Lucas M Bronicki; Vladimir Ljubicic; Jean-Marc Renaud; Bernard J Jasmin
Journal:  Hum Mol Genet       Date:  2015-10-22       Impact factor: 6.150

7.  Fibroblast growth factor 1 induced during myogenesis by a transcription-translation coupling mechanism.

Authors:  Caroline Conte; Nadera Ainaoui; Aurélie Delluc-Clavières; Marie P Khoury; Rania Azar; Françoise Pujol; Yvan Martineau; Stéphane Pyronnet; Anne-Catherine Prats
Journal:  Nucleic Acids Res       Date:  2009-06-26       Impact factor: 16.971

8.  Oral quercetin administration transiently protects respiratory function in dystrophin-deficient mice.

Authors:  Joshua T Selsby; Christopher G Ballmann; Hannah R Spaulding; Jason W Ross; John C Quindry
Journal:  J Physiol       Date:  2016-05-29       Impact factor: 5.182

9.  Targeting artificial transcription factors to the utrophin A promoter: effects on dystrophic pathology and muscle function.

Authors:  Yifan Lu; Chai Tian; Gawiyou Danialou; Rénald Gilbert; Basil J Petrof; George Karpati; Josephine Nalbantoglu
Journal:  J Biol Chem       Date:  2008-10-21       Impact factor: 5.157

10.  Ets-2 repressor factor silences extrasynaptic utrophin by N-box mediated repression in skeletal muscle.

Authors:  Kelly J Perkins; Utpal Basu; Murat T Budak; Caroline Ketterer; Santhosh M Baby; Olga Lozynska; John A Lunde; Bernard J Jasmin; Neal A Rubinstein; Tejvir S Khurana
Journal:  Mol Biol Cell       Date:  2007-05-16       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.